Healthy women test new version of cancer drug
NCT ID NCT06742086
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 22 times
Summary
This study looked at how a new tablet form of the drug venetoclax is absorbed in the body. 72 healthy women took the new tablet and the current tablet to compare them. The study also checked if eating a high-fat meal changes how the new tablet works. This was a phase 1 study with no direct health benefit for participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acpru /Id# 272979
Grayslake, Illinois, 60030, United States
-
PPD Phase I Clinic /ID# 275754
Austin, Texas, 78744, United States
Conditions
Explore the condition pages connected to this study.